Cerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 Sales

Cerus Corp's CERS Q4 FY21 product revenue was $39.9 million, compared to $28.2 million, driven by increased sales of INTERCEPT platelet kits to blood center customers across the U.S.

  • Total revenue increased 49% to $50.1 million, beating the consensus of $44.2 million.
  • Product gross profit was $20.4 million and, for the second consecutive quarter, was the highest in the company's history, increasing by $4.4 million over the prior-year period. 
  • Product gross margin was 51.1% compared to 56.8% for the fourth quarter of 2020 and roughly flat compared to the second and third quarters of 2021.
  • The company said that a decrease in product gross margin was anticipated, as U.S. customers primarily use single-dose platelet kits, which have a lower margin than double dose kits, which the company's international customers more typically use.
  • Cerus posted a EPS loss of $(0.05), lower than $(0.09) a year ago and the consensus of $(0.08).
  • The company held cash and equivalents of $129.4 million as of December 31, 2021.
  • Cerus carried $54.7 million of notes due and a balance on its revolving line of credit of $14.7 million. The company continues to have access to $5 million under its revolving line of credit.
  • Guidance: Cerus reiterated the FY22 product revenue outlook of $157 million - $164 million, representing approximately 20%-25% Y/Y growth.
  • Price Action: CERS shares closed lower by 1.50% at $5.25 on Tuesday.

Posted In: BriefsEarningsNewsGuidanceHealth CareSmall CapGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.